Funder: Hypersomnia Foundation
Due Dates: September 2027 (next annual letter-of-intent cycle opens)
Funding Amounts: Three grant categories: up to $50,000, $100,000, or $250,000
Summary: Supports research into hypersomnia causes, diagnostic tools, and treatments, emphasizing idiopathic hypersomnia and its overlap with narcolepsy type 2.
Key Information: Researchers worldwide may apply; AASM membership is not required.
Description
The Hypersomnia Foundation (HF) and the AASM Foundation jointly fund the Strategic Research Grant each year to advance research into hypersomnia sleep disorders. The partnership supports work to identify their causes and improve diagnosis and effective treatment for people living with these conditions. Although HF is interested in all primary hypersomnias, its main focus is idiopathic hypersomnia and its overlap with narcolepsy type 2.
Research priorities include identifying phenotypes and causes, developing biomarkers and quantitative assessment tools, evaluating medicines, and creating personalized treatment protocols. HF is particularly interested in projects that could generate findings supporting larger research grant applications, such as those to the NIH.
